AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Higher occupancy of muscarinic receptors by olanzapine than risperidone inpatients with schizophrenia - A [I-123]-IDEX SPECT study
Authors: Lavalaye, J Booij, J Linszen, DH Reneman, L van Royen, EA
Citation: J. Lavalaye et al., Higher occupancy of muscarinic receptors by olanzapine than risperidone inpatients with schizophrenia - A [I-123]-IDEX SPECT study, PSYCHOPHAR, 156(1), 2001, pp. 53-57
Dopamine transporter density in patients with tardive dyskinesia: a singlephoton emission computed tomography study
Authors: Lavalaye, J Sarlet, A Booij, J Linszen, DH Reneman, L Gersons, BPR van Royen, EA
Citation: J. Lavalaye et al., Dopamine transporter density in patients with tardive dyskinesia: a singlephoton emission computed tomography study, PSYCHOPHAR, 155(1), 2001, pp. 107-109
Dopamine transporter density in young patients with schizophrenia assessedwith [(123)] FP-CIT SPECT
Authors: Lavalaye, J Linszen, DH Booij, J Dingemans, PMAJ Reneman, L Habraken, BAJ Gersons, BPR van Royen, EA
Citation: J. Lavalaye et al., Dopamine transporter density in young patients with schizophrenia assessedwith [(123)] FP-CIT SPECT, SCHIZOPHR R, 47(1), 2001, pp. 59-67
Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [I-123]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus
Authors: Reneman, L De Bruin, K Lavalaye, J Gunning, WB Booij, J
Citation: L. Reneman et al., Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [I-123]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus, SYNAPSE, 39(3), 2001, pp. 193-200
Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease
Authors: Booij, J Bergmans, P Winogrodzka, A Speelman, JD Wolters, EC
Citation: J. Booij et al., Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease, SYNAPSE, 39(2), 2001, pp. 101-108
Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients
Authors: Winogrodzka, A Wagenaar, RC Bergmans, P Vellinga, A Booij, J van Royen, EA van Emmerik, REA Stoof, JC Wolters, EC
Citation: A. Winogrodzka et al., Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients, MOVEMENT D, 16(6), 2001, pp. 1033-1040
Dopamine transporter imaging as an in vivo marker of dopaminergic neurons
Authors: Booij, J Reneman, L Lavalaye, J Knol, RJJ de Bruin, K Speelman, JD Janssen, AGM
Citation: J. Booij et al., Dopamine transporter imaging as an in vivo marker of dopaminergic neurons, DRUG FUTURE, 26(3), 2001, pp. 271-279
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
Authors: Berendse, HW Booij, J Francot, CMJE Bergmans, PLM Hijman, R Stoof, JC Wolters, EC
Citation: Hw. Berendse et al., Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell, ANN NEUROL, 50(1), 2001, pp. 34-41
The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism
Authors: Booij, J Speelman, JD Horstink, MWIM Wolters, EC
Citation: J. Booij et al., The clinical benefit of imaging striatal dopamine transporters with [I-123]FP-CIT SPET in differentiating patients with presynaptic parkinsonism fromthose with other forms of parkinsonism, EUR J NUCL, 28(3), 2001, pp. 266-272
[I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease
Authors: Winogrodzka, A Bergmans, P Booij, J van Royen, EA Janssen, AGM Wolters, EC
Citation: A. Winogrodzka et al., [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease, J NEURAL TR, 108(8-9), 2001, pp. 1011-1019
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
Authors: Reneman, L Booij, J de Bruin, K Reitsma, JB de Wolff, FA Gunning, WB den Heeten, GL van den Brink, W
Citation: L. Reneman et al., Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons, LANCET, 358(9296), 2001, pp. 1864-1869
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
Authors: van de Warrenburg, BPC Lammens, M Lucking, CB Denefle, P Wesseling, P Booij, J Praamstra, P Quinn, N Brice, A Horstink, MWIM
Citation: Bpc. Van De Warrenburg et al., Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations, NEUROLOGY, 56(4), 2001, pp. 555-557
Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") - Preliminary findings
Authors: Reneman, L Lavalaye, J Schmand, B de Wolff, FA van den Brink, W den Heeten, GJ Booij, J
Citation: L. Reneman et al., Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") - Preliminary findings, ARCH G PSYC, 58(10), 2001, pp. 901-906
Dopamine D-2 receptor blockade in schizophrenia - Dr. de Haan and colleagues reply
Authors: De Haan, L Lavalaye, J Linszen, D Dingemans, PMAJ Booij, J
Citation: L. De Haan et al., Dopamine D-2 receptor blockade in schizophrenia - Dr. de Haan and colleagues reply, AM J PSYCHI, 158(6), 2001, pp. 972-972
Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission
Authors: Reneman, L Booij, J Schmand, B van den Brink, W Gunning, B
Citation: L. Reneman et al., Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission, PSYCHOPHAR, 148(3), 2000, pp. 322-324
Accurate differentiation of parkinsonism and essential tremor using visualassessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group
Authors: Benamer, HTS Patterson, J Grosset, DG Booij, J de Bruin, K van Royen, E Speelman, JD Horstink, MHIM Sips, HJWA Dierckx, RA Versijpt, J Decoo, D Van der Linden, C Hadley, DM Doder, M Lees, AJ Costa, DC Gacinovic, S Oertel, WH Pogarell, O Hoeffken, H Joseph, K Tatsch, K Schwarz, J Ries, V
Citation: Hts. Benamer et al., Accurate differentiation of parkinsonism and essential tremor using visualassessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group, MOVEMENT D, 15(3), 2000, pp. 503-510
Effect of age and gender on dopamine transporter imaging with [I-123]FP-CIT SPET in healthy volunteers
Authors: Lavalaye, J Booij, J Reneman, L Habraken, JBA van Royen, EA
Citation: J. Lavalaye et al., Effect of age and gender on dopamine transporter imaging with [I-123]FP-CIT SPET in healthy volunteers, EUR J NUCL, 27(7), 2000, pp. 867-869
[I-123]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication
Authors: Lavalaye, J Knol, RJJ de Bruin, K Reneman, L Janssen, AGM Booij, J
Citation: J. Lavalaye et al., [I-123]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication, EUR J NUCL, 27(3), 2000, pp. 346-349
Preclinical (premotor) Parkinson's disease
Authors: Wolters, EC Francot, C Bergmans, P Winogrodzka, A Booij, J Berendse, HW Stoof, JC
Citation: Ec. Wolters et al., Preclinical (premotor) Parkinson's disease, J NEUROL, 247, 2000, pp. 103-109
MDMA ("Ecstasy") and its association with cerebrovascular accidents: Preliminary findings
Authors: Reneman, L Habraken, JBA Majoie, CBL Booij, J den Heeten, GJ
Citation: L. Reneman et al., MDMA ("Ecstasy") and its association with cerebrovascular accidents: Preliminary findings, AM J NEUROR, 21(6), 2000, pp. 1001-1007
Subjective experience and striatal dopamine D-2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone
Authors: de Haan, L Lavalaye, J Linszen, D Dingemans, PMAJ Booij, J
Citation: L. De Haan et al., Subjective experience and striatal dopamine D-2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone, AM J PSYCHI, 157(6), 2000, pp. 1019-1020
Dopamine D-2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia
Authors: Lavalaye, J Linszen, DH Booij, J Reneman, L Gersons, BPR van Royen, EA
Citation: J. Lavalaye et al., Dopamine D-2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia, PSYCH RES-N, 92(1), 1999, pp. 33-44
Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain
Authors: Reneman, L Booij, J Lavalaye, J De Bruin, K De Wolff, FA Koopmans, RP Stoof, JC Den Heeten, GJ
Citation: L. Reneman et al., Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain, SYNAPSE, 34(1), 1999, pp. 77-80
Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism
Authors: Booij, J Tissingh, G Winogrodzka, A van Royen, EA
Citation: J. Booij et al., Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism, EUR J NUCL, 26(2), 1999, pp. 171-182
Quantification and visualization of defects of the functional dopaminergicsystem using an automatic algorithm
Authors: Habraken, JBA Booij, J Slomka, P Sokole, EB van Royen, EA
Citation: Jba. Habraken et al., Quantification and visualization of defects of the functional dopaminergicsystem using an automatic algorithm, J NUCL MED, 40(7), 1999, pp. 1091-1097
Risultati: 1-25 | 26-28